Why This Physician Is Suing the DEA Over Psilocybin
How Psilocybin and Ketamine Are Helping Terminally Ill Patients
Entheogens: The Spiritual Side of Psychedelic Medicine
Eye-Opening Insights on The Emerging Psilocybin Industry
Full Interview with Dr. Sunil Aggarwal | The Edge Presented by The Bluntness
Supporting women in the wild with science and wisdom about psychedelics. 134. Psychedelics and Grief: When Containment Stops Working Dr. Sunil Aggarwal joins April Pride to talk psilocybin, grief, and the difference between containing a loss and integrating it. April Pride Sep 29 Recently, it occurred to me that my relationship with trust needed tending. When I told a friend, she asked, “Why don’t you trust yourself?” I’ve been sitting with that question because it tracks and it confuses me at the same time. I’ve walked into divorce, entrepreneurship, and work in the Schedule I-adjacent world. Not the choices of ...
How Academy Members Are Integrating Psychedelics to Ease Distress Catherine Arnold For patients facing serious illness, some of the deepest suffering cannot be measured on a numerical scale. Some patients experience anxiety that does not respond to conventional treatment, as well as a deep sense of demoralization, isolation, and loss of meaning. Palliative and hospice care have long recognized treatment of this existential distress as central to whole-person care. Now, an emerging field of research is asking whether psychedelic-assisted therapy (PAT)—a structured protocol that combines the administration of a psychoactive compound with guided professional psychotherapy before, during, and after the ...
8 CONTINUING EDUCATION (CE) HOURS FEBRUARY 1–4, 2027OPIHIHALE ETHNOBOTANICAL PRESERVEBig Island, Hawai‘i $2,850 INCLUDES Three nights lodging | All mealsGround transportation to and from Kona AirportCourse materials | Guided ethnobotanical tour AIMS Institute in collaboration with Opihihale Ethnobotanical Preserve WHY THIS COURSE? As interest in psychedelic therapies continues to grow, naturopathic physicians are increasingly asked about their safety, effectiveness, legal status, and appropriate clinical use. This immersive continuing education program provides an evidence-based review of current psychedelic science together with practical harm reduction strategies for clinicians whose patients are considering or using psychedelic medicines. Presented by the AIMS Institute in ...
We and the services embedded in this site — analytics, advertising, booking, maps and translation — collect information about your visit, including your IP address, your browser and the pages you view. Some of that information is shared with those companies. This happens as you browse. Read our Cookie Policy.
